Arkolith/Insider Trading/CDTX/Form 4

Karbe Frank

Chief Financial OfficerCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Jan 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)8K$221.50$1.7M43K
Jan 7, 2026Disposed to issuer(D)43K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)115K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001276700-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML